Rainer D. Will
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 4
-
- Signaling Pathways in Disease 5
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Norbert Frey (13 shared papers)Hugo Albert Katus (12 shared papers)Stefan Wiemann (14 shared papers)Derk Frank (11 shared papers)Christian Kühn (10 shared papers)Alexander Bott (2 shared papers)Ioanna Keklikoglou (2 shared papers)Thomas Romig (2 shared papers)
- Journals
- Nature Communications (4 papers)Circulation Research (3 papers)Journal of Molecular and Cellular Cardiology (3 papers)Molecular Oncology (2 papers)Cancers (2 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Rainer D. Will
54 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 356
- Molecular Biology 1.0k
- Oncology 327
- Cardiology and Cardiovascular Medicine 270
- Pathology and Forensic Medicine 190
Countries citing papers authored by Rainer D. Will
This map shows the geographic impact of Rainer D. Will's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer D. Will with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer D. Will more than expected).
Fields of papers citing papers by Rainer D. Will
This network shows the impact of papers produced by Rainer D. Will. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer D. Will. The network helps show where Rainer D. Will may publish in the future.
Co-authors
The 25 scholars most cited alongside Rainer D. Will, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 231 | |
| 2 | 2019 | 156 | |
| 3 | 2008 | 120 | |
| 4 | 2014 | 113 | |
| 5 | 2016 | 109 | |
| 6 | 2017 | 100 | |
| 7 | 2022 | 85 | |
| 8 | 2015 | 80 | |
| 9 | 2009 | 70 | |
| 10 | 2010 | 63 | |
| 11 | Candidate genes for cross-resistance against DNA-damaging drugs. | 2002 | 62 |
| 12 | 2011 | 62 | |
| 13 | 1997 | 57 | |
| 14 | 2012 | 52 | |
| 15 | 2007 | 51 | |
| 16 | 2010 | 49 | |
| 17 | 2010 | 44 | |
| 18 | 2005 | 41 | |
| 19 | 2021 | 41 | |
| 20 | 2018 | 39 |
About Rainer D. Will
Rainer D. Will is a scholar working on Cancer Research, Molecular Biology, Genetics, Oncology and Cardiology and Cardiovascular Medicine, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Signaling Pathways in Disease (5 papers), Cardiomyopathy and Myosin Studies (5 papers), RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Glioma Diagnosis and Treatment (4 papers), Epigenetics and DNA Methylation (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (356 citations), Molecular Biology (1.0k citations), Oncology (327 citations), Cardiology and Cardiovascular Medicine (270 citations) and Pathology and Forensic Medicine (190 citations). Rainer D. Will has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Norbert Frey, Hugo Albert Katus, Stefan Wiemann, Derk Frank, Christian Kühn, Alexander Bott, Ioanna Keklikoglou, Thomas Romig, Christian Breunig and Richard Lucius. Their work appears in journals such as Nature Communications, Circulation Research, Journal of Molecular and Cellular Cardiology, Molecular Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.